Peptide compounds derived from melanotransferrin and uses thereof
US9334314B2 · kind B2 · utility
0Cited by
1References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 18, 2012 |
| Grant date | May 10, 2016 |
| Priority date | — |
| Expiry date | Oct 18, 2032 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/40
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Peptide compounds derived from human melanotransferrin, and compositions thereof, are described. Uses of these peptide compounds, for example to modulate angiogenesis and/or cell migration, and/or to treat angiogenesis-related disorders (e.g., cancer), are also described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.